CDK4 and leiomyosarcoma: In addition, in Brazilian cohorts, amplification or overrepresentation of CDK4 was evinced through qRT-PCR and immunoreactivity in both forms of RMS (ERMS and ARMS), along with several leiomyosarcoma samples [399,400].